May 2021

Ali Salanti from VAR2 Pharmaceuticals shared information, on day two of the 2021 European Biotech Start-up Symposium, about his company’s research and development using a recombinant cancer binding malaria protein to diagnose, target, and treat cancer. VAR2 was last year’s grant winner but they were unable to give their presentation due to the COVID-19 pandemic …

VAR2 Pharmaceuticals is Targeting Cancer Cells Using a Malaria Protein Read More »

Two of the presentations at the 2021 European Biotech Start-up Symposium last month centered on geographical areas focused on R&D and biotechnology. Ned Wakeman presented on the Alderly Park in the UK, and Julia Schaft discussed the life science cluster of the Rhine-Neckar region of Germany. Per Wakeman, as a result of a closure of …

Two Regions Becoming Hubs of Biotechnology R&D Activity Read More »

While a variety of topics were covered during the Biotech Start-Up Symposium in April, a recurring theme was the importance of raising venture capital to fund new technology research and development. In her presentation, Therese Maria Liechtenstein from M Ventures reviewed how successful startup companies raise venture capital. She outlined the steps involved in fund-raising, …

Raising Venture Capital Is Key to the Success of New Technology Research and Development Read More »

Tech transfer appears on the agenda of almost every biotech company. After identifying a suitable molecule, biotechs need support from external partners on the way to commercialization. However, many fear that tech transfer could slow them down or that they may be locked in with royalty fees. Working with the right partner can make all …

CDMO: Afraid of tech transfer? There’s no need! Read More »